Ignite Creation Date:
2025-12-24 @ 4:43 PM
Ignite Modification Date:
2026-02-22 @ 9:38 AM
Study NCT ID:
NCT02065466
Status:
WITHDRAWN
Last Update Posted:
2016-04-21
First Post:
2014-02-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Combo of Abraxane, TMZ, Bevacizumab in Metastatic Melanoma With Brain Metastases
Sponsor:
University of Arizona
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-07
Start Date Type:
None
Primary Completion Date:
2015-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-08
Completion Date Type:
ACTUAL
First Submit Date:
2014-02-06
First Submit QC Date:
None
Study First Post Date:
2014-02-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-04-20
Last Update Post Date:
2016-04-21
Last Update Post Date Type:
ESTIMATED